Gazyva
obinutuzumab
Listed by Genentech, Inc.
- Strength
- 1000 mg/40mL
- Form
- Injection, Solution, Concentrate
- Route
- Intravenous
- Class
- CD20-directed Cytolytic Antibody
What it contains
- Obinutuzumab 1000 mg/40mL
FDA record
| Dosage form | Injection, Solution, Concentrate |
|---|---|
| Route | Intravenous |
| Drug class | CD20-directed Cytolytic Antibody |
| Approval route | BLA — biologic licence |
| NDC code | 50242-070 |
| FDA application | BLA125486 |
| RxNorm concept | 1442693 |
| Package sizes listed | 2 |
| Marketed since | November 2013 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.